Clinical trial
A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
NCT05624723 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
- Lead sponsor
- Incyte Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 12, 2023
- Completion date
- February 7, 2024
- Enrollment
- 43 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.